FDA OK ' s Novartis Biosimilar to Amgen Arthritis Drug, Enbrel

Sandoz, a division of Novartis, announces FDA approves Erelzi to treat multiple inflammatory diseases
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news